Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1973 2
1975 3
1976 1
1977 1
1978 1
1979 1
1980 4
1981 1
1982 1
1983 1
1984 5
1985 4
1986 4
1987 3
1988 3
1989 3
1990 8
1991 3
1992 2
1993 3
1994 4
1995 4
1996 4
1997 7
1998 6
1999 5
2000 7
2001 3
2002 7
2003 14
2004 8
2005 13
2006 9
2007 13
2008 9
2009 8
2010 8
2011 8
2012 9
2013 10
2014 7
2015 16
2016 8
2017 6
2018 13
2019 8
2020 7
2021 4
2022 1
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

264 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Metastatic Vaginal Adenocarcinoma"
Page 1
Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial.
Nout RA, Smit VT, Putter H, Jürgenliemk-Schulz IM, Jobsen JJ, Lutgens LC, van der Steen-Banasik EM, Mens JW, Slot A, Kroese MC, van Bunningen BN, Ansink AC, van Putten WL, Creutzberg CL; PORTEC Study Group. Nout RA, et al. Lancet. 2010 Mar 6;375(9717):816-23. doi: 10.1016/S0140-6736(09)62163-2. Lancet. 2010. PMID: 20206777 Clinical Trial.
BACKGROUND: After surgery for intermediate-risk endometrial carcinoma, the vagina is the most frequent site of recurrence. This study established whether vaginal brachytherapy (VBT) is as effective as pelvic external beam radiotherapy (EBRT) in prevention of vagi …
BACKGROUND: After surgery for intermediate-risk endometrial carcinoma, the vagina is the most frequent site of recurrence. This study …
Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC Study Group. Post Operative Radiation Therapy in Endometrial Carcinoma.
Creutzberg CL, van Putten WL, Koper PC, Lybeert ML, Jobsen JJ, Wárlám-Rodenhuis CC, De Winter KA, Lutgens LC, van den Bergh AC, van de Steen-Banasik E, Beerman H, van Lent M. Creutzberg CL, et al. Lancet. 2000 Apr 22;355(9213):1404-11. doi: 10.1016/s0140-6736(00)02139-5. Lancet. 2000. PMID: 10791524 Clinical Trial.
The primary study endpoints were locoregional recurrence and death, with treatment-related morbidity and survival after relapse as secondary endpoints. FINDINGS: Analysis was done according to the intention-to-treat principle. ...Grade 3-4 complications were seen in eight …
The primary study endpoints were locoregional recurrence and death, with treatment-related morbidity and survival after relapse as second …
Substantial lymph-vascular space invasion (LVSI) is a significant risk factor for recurrence in endometrial cancer--A pooled analysis of PORTEC 1 and 2 trials.
Bosse T, Peters EE, Creutzberg CL, Jürgenliemk-Schulz IM, Jobsen JJ, Mens JW, Lutgens LC, van der Steen-Banasik EM, Smit VT, Nout RA. Bosse T, et al. Eur J Cancer. 2015 Sep;51(13):1742-50. doi: 10.1016/j.ejca.2015.05.015. Epub 2015 Jun 3. Eur J Cancer. 2015. PMID: 26049688 Clinical Trial.
BACKGROUND: Lymph-vascular space invasion (LVSI) is an important adverse prognostic factor in endometrial cancer (EC). However, its role in relation to type of recurrence and adjuvant treatment is not well defined, and there is significant interobserver variation. ...CONCL …
BACKGROUND: Lymph-vascular space invasion (LVSI) is an important adverse prognostic factor in endometrial cancer (EC). However, its r …
Lateral Pelvic Sidewall Nodes.
Kelly ME, Heriot AG. Kelly ME, et al. Dis Colon Rectum. 2023 Mar 1;66(3):355-357. doi: 10.1097/DCR.0000000000002706. Epub 2023 Jan 4. Dis Colon Rectum. 2023. PMID: 36728599
There was no evidence of distant disease. The patient underwent long-course neoadjuvant chemoradiotherapy. Restaging showed a good treatment response with some regression and no involvement/encroachment of the vagina. ...Final histopathology confirmed a moderately d …
There was no evidence of distant disease. The patient underwent long-course neoadjuvant chemoradiotherapy. Restaging showed a good tr …
Staging for vaginal cancer.
Rajaram S, Maheshwari A, Srivastava A. Rajaram S, et al. Best Pract Res Clin Obstet Gynaecol. 2015 Aug;29(6):822-32. doi: 10.1016/j.bpobgyn.2015.01.006. Epub 2015 Mar 4. Best Pract Res Clin Obstet Gynaecol. 2015. PMID: 25847318 Review.
Vaginal cancer is a rare cancer comprising about 3% of all gynecologic cancers. Primary vaginal cancer should be carefully assigned as spread from cervix, vulva, and other metastatic tumors to vagina can occur. ...
Vaginal cancer is a rare cancer comprising about 3% of all gynecologic cancers. Primary vaginal cancer should be carefully ass …
Diagnostic and Therapeutic Approach in a Metastatic Vaginal Adenocarcinoma: A Case Report.
Egger EK, Ralser DJ, Lindner K, Recker F, Marinova M, Savchenko O, Lau JF, Mustea A. Egger EK, et al. Front Immunol. 2021 Jul 23;12:686879. doi: 10.3389/fimmu.2021.686879. eCollection 2021. Front Immunol. 2021. PMID: 34367146 Free PMC article.
BACKGROUND: Vaginal adenocarcinomas (VAC) are most often reported after intrauterine exposition to diethylstilbestrol (DES). ...VACs without DES exposition have a poor prognosis and a significantly worse outcome compared to vaginal squamous cell carcin …
BACKGROUND: Vaginal adenocarcinomas (VAC) are most often reported after intrauterine exposition to diethylstilbestrol (DES). . …
Placental site trophoblastic tumour.
Kim SJ. Kim SJ. Best Pract Res Clin Obstet Gynaecol. 2003 Dec;17(6):969-84. doi: 10.1016/s1521-6934(03)00095-6. Best Pract Res Clin Obstet Gynaecol. 2003. PMID: 14614893 Review.
PSTT can occur after a normal pregnancy, abortion, term delivery, ectopic pregnancy or molar pregnancy. It displays a wide clinical spectrum, and when metastatic, can be difficult to control even with surgery and chemotherapy. ...Advances in chemotherapeutic regimens have …
PSTT can occur after a normal pregnancy, abortion, term delivery, ectopic pregnancy or molar pregnancy. It displays a wide clinical spectrum …
Clinicopathologic Review of Metastatic Breast Cancer to the Gynecologic Tract.
Braun A, Reddy S, Cheng L, Gattuso P, Yan L. Braun A, et al. Int J Gynecol Pathol. 2023 Jul 1;42(4):414-420. doi: 10.1097/PGP.0000000000000920. Epub 2022 Oct 10. Int J Gynecol Pathol. 2023. PMID: 36563298
Metastatic spread is the single most significant predictor of poor survival in breast cancer. ...Metastatic breast cancer rarely involved the lower gynecologic tract, with only 7% vaginal metastasis and 4% found in the vulva. ...
Metastatic spread is the single most significant predictor of poor survival in breast cancer. ...Metastatic breast canc …
Small-cell carcinoma of the endometrium. A clinicopathological study of sixteen cases.
Huntsman DG, Clement PB, Gilks CB, Scully RE. Huntsman DG, et al. Am J Surg Pathol. 1994 Apr;18(4):364-75. doi: 10.1097/00000478-199404000-00005. Am J Surg Pathol. 1994. PMID: 7511354 Review.
Of the 12 patients whose presenting features are known, eight had abnormal vaginal bleeding, three had pain related to metastatic tumor, and one patient had both symptoms. ...In three cases, the adenocarcinoma merged almost imperceptibly with the small-cell c …
Of the 12 patients whose presenting features are known, eight had abnormal vaginal bleeding, three had pain related to metastatic …
Neuroendocrine tumors of the genital tract.
Eichhorn JH, Young RH. Eichhorn JH, et al. Am J Clin Pathol. 2001 Jun;115 Suppl:S94-112. doi: 10.1309/64CW-WKGK-49EF-BYD1. Am J Clin Pathol. 2001. PMID: 11993694 Review.
Small cell neuroendocrine carcinomas also occur rarely in the vagina and vulva. Most male genital tract neuroendocrine tumors are prostatic small cell carcinomas or testicular carcinoids. Extragonadal carcinoids of the male genital tract are rare. Testicular carcinoids sho …
Small cell neuroendocrine carcinomas also occur rarely in the vagina and vulva. Most male genital tract neuroendocrine tumors are pro …
264 results